Further, the BH3 profiling results indicated that the effects of Gal3 on apoptosis sensitivity in USC varies among different lines and, given what we observed in our ovarian cancer model, could differ with tumor type, histology and molecular or oncogenic drivers for each patient. This evidence concerns the gene LGALS3 and ovarian carcinoma.